Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

These may range from a mildly symptomatic clinical picture to one characterised by chest pain, heart failure and cardiogenic shock necessitating mechanical circulatory support, as well as ...